Therefore, these results suggest that the aberration of HOXA10-AS has pro-metastatic effects in KMT2A-r leukemias and that HOXA10-AS inhibition may be a viable strategy for KMT2A-r leukemias. Here, HOXA10 is linked to leukemia.